EXHIBIT C
STOCK PURCHASE AGREEMENT
THIS STOCK PURCHASE AGREEMENT (this "Agreement") is made and entered into
as of June 10, 1999, between Global Sports, Inc., a Delaware corporation (the
"Company"), and SOFTBANK America Inc., a Delaware corporation (the "Purchaser").
ARTICLE I
AUTHORIZATION AND SALE OF STOCK
Section 1.1 SALE OF THE SHARES. Subject to the terms and conditions hereof,
at the Closings (as defined in Section 2.1 hereof), the Company shall issue and
sell to the Purchaser, and the Purchaser shall purchase from the Company, the
total number of shares (collectively, the "Shares") of common stock, par value
$0.01 per share ("Common Stock"), of the Company specified on the Schedule of
Purchases attached hereto as Exhibit A, at a purchase price per Share equal to
$13.00, for an aggregate purchase price of $80,000,050 in cash in immediately
available funds.
ARTICLE II
CLOSING DATE; DELIVERY
Section 2.1 CLOSINGS AND LOCATION. The purchase and sale of the Shares
hereunder shall take place at two closings (individually, a "Closing" and,
collectively, the "Closings") at the offices of Xxxxxxxx & Xxxxxxxx, 0000
Xxxxxxx Xxxx Xxxx, Xxx Xxxxxxx, Xxxxxxxxxx 00000, at 10:00 a.m., California
time, on the dates hereinafter specified.
Section 2.2 FIRST CLOSING. The Closing of the purchase and sale of the
Shares designated for issuance at the first Closing (the "First Purchase") as
set forth on the Schedule of Purchases (the "First Closing") shall be held on
the later to occur of (i) July 15, 1999 or, if earlier, such date as SOFTBANK
Capital Partners, L.P. ("SOFTBANK Capital Partners") is formed as a Delaware
limited partnership and
-1-
has consummated the first closing with investors therein, (ii) the first
business day following the date on which the last to be fulfilled or waived of
the conditions to the First Closing set forth in Sections 6.1 and 6.2 hereof
have been fulfilled or waived in accordance with this Agreement or (iii) such
other date as is mutually agreed to by the Company and the Purchaser. The date
of the First Closing is hereinafter referred to as the "First Closing Date."
Section 2.3 SECOND CLOSING. The Closing of the purchase and sale of the
Shares designated for issuance at the second Closing (the "Second Purchase") as
set forth on the Schedule of Purchases (the "Second Closing") shall be held on
the latest to occur of (i) the first business day following the date on which
the last to be fulfilled or waived of the conditions to the Second Closing set
forth in Sections 6.1 and 6.2 hereof have been fulfilled or waived in accordance
with this Agreement, (ii) such other date as is mutually agreed to by the
Company and the Purchaser or (iii) the First Closing Date. The date of the
Second Closing is hereinafter referred to as the "Second Closing Date," and the
First Closing Date and the Second Closing Date are hereinafter collectively
referred to as the "Closing Dates."
Section 2.4 DELIVERY. Subject to the terms and conditions of this
Agreement, at each Closing, the Company shall deliver to the Purchaser a stock
certificate or certificates representing the Shares to be purchased by the
Purchaser at such Closing, registered in the name of the Purchaser or its
assigns, against payment of the purchase price therefor. The purchase price of
the Shares to be purchased at the First Closing shall be paid by automatic
conversion of the Convertible Subordinated Note (as defined in the Subordinated
Loan Agreement between the Company and the Purchaser dated as of the date
hereof) in the principal amount of $15.0 million, dated the date hereof, issued
by the Company in favor of the Purchaser in accordance with its terms in
exchange for the number of shares issuable upon such conversion as provided
therein (the "Conversion Number") and by wire transfer in immediately available
funds to an account designated in writing by the Company of an
-2-
amount equal to the product (i) the difference equal to (A) the number of Shares
to be purchased by the Purchaser at such Closing minus (B) the Conversion Number
times (ii) $13.00. The purchase price of the Shares to be purchased at the
Second Closing shall be paid by wire transfer of $48,375,054 in immediately
available funds to an account designated in writing by the Company for such
purpose.
Section 2.5 CONSUMMATION OF CLOSING. All acts, deliveries and confirmations
comprising each Closing regardless of chronological sequence shall be deemed to
occur contemporaneously and simultaneously upon the occurrence of the last act,
delivery or confirmation of such Closing and none of such acts, deliveries or
confirmations shall be effective unless and until the last of same shall have
occurred.
ARTICLE III
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
The Company hereby represents and warrants to the Purchaser as follows:
Section 3.1 ORGANIZATION. The Company is a corporation duly organized,
validly existing and in good standing under the laws of the State of Delaware
and has all requisite corporate power to own, lease and operate its property and
to carry on its business as now being conducted and is duly qualified to do
business and is in good standing in each jurisdiction where it is required to be
so qualified and in good standing, except for any such jurisdiction in which the
failure to be so qualified and in good standing would not, individually or in
the aggregate, have a material adverse effect on the business, financial
condition, results of operations or prospects of the Company (a "Material
Adverse Effect").
Section 3.2 SUBSIDIARIES. Each of the Company's subsidiaries is a
corporation duly organized, validly existing in good standing under the laws of
the jurisdiction
-3-
of its organization, and is duly qualified to do business and in good standing
in the jurisdictions where it is required to be so qualified and is in good
standing, except for any such jurisdiction in which the failure to be so
qualified and in good standing would not, individually or in the aggregate, have
a Material Adverse Effect.
Section 3.3 VALID ISSUANCE OF COMMON STOCK. The Shares, when issued and
paid for in accordance with this Agreement, will be duly authorized, validly
issued, fully paid and non-assessable.
Section 3.4 AUTHORITY; NO CONFLICT; REQUIRED FILINGS
AND CONSENTS.
(a) The Company has all requisite corporate power and authority to
enter into this Agreement, the Registration Rights Agreement in the form
attached hereto as Exhibit B (the "Registration Rights Agreement"), the
Subordinated Loan Agreement between the Company and the Purchaser dated as of
the date hereof (the "Loan Agreement") and the Convertible Subordinated Note and
to consummate the transactions contemplated by this Agreement and the
Registration Rights Agreement, the Loan Agreement and the Convertible
Subordinated Note. This Agreement, the Loan Agreement, the Convertible
Subordinated Note and the Registration Rights Agreement have been duly
authorized, executed and delivered by the Company and constitute valid and
legally binding obligations of the Company, enforceable against the Company in
accordance with their terms, subject to bankruptcy, insolvency, fraudulent
transfer, reorganization, moratorium and similar laws of general applicability
relating to or affecting creditors' rights and to general equity principles;
provided, however, that it is understood that pursuant to the regulations of the
National Association of Securities Dealers, Inc. (the "NASD Rules"), stockholder
approval of the consummation of the Second Purchase is required prior to such
consummation.
(b) The execution and delivery by the Company of this Agreement, the
Registration Rights Agreement, the Loan Agreement and the Convertible
Subordinated Note does not,
-4-
and consummation of the transactions contemplated by this Agreement, the
Registration Rights Agreement, the Loan Agreement and the Convertible
Subordinated Note will not, (i) conflict with, or result in any violation or
breach of any provision of, the Certificate of Incorporation or Bylaws of the
Company, (ii) result in any violation or breach of, or constitute (with or
without notice or lapse of time, or both) a default (or give rise to a right of
termination, cancellation or acceleration of any obligation or loss of any
material benefit) under, any of the terms, conditions or provisions of any note,
bond, mortgage, indenture, lease, contract or other agreement, instrument or
obligation to which the Company or any of its subsidiaries is a party or by
which the Company or any of its subsidiaries, properties or assets may be bound,
or (iii) conflict with or violate any permit, concession, franchise, license,
judgment, order, decree, statute, law, ordinance, rule or regulation applicable
to the Company or any of its subsidiaries, properties or assets (provided, with
respect to clauses (ii) and (iii), with respect to the Shares to be purchased at
the Second Closing, that stockholder approval of such purchase is obtained in
conformity with the NASD Rules prior to the Second Closing), except in the case
of (ii) and (iii) for any such violations, defaults, breaches, terminations,
cancellations, accelerations, losses or conflicts which would not, individually
or in the aggregate, have a Material Adverse Effect, and would not materially
burden or delay the consummation of the transactions contemplated hereby.
(c) No consent, approval, order or authorization of, or registration,
declaration or filing with, any court, administrative agency or commission or
other governmental authority or instrumentality (a "Governmental Entity") is
required by or with respect to the Company in connection with the execution and
delivery of this Agreement, the Registration Rights Agreement, the Loan
Agreement and the Convertible Subordinated Note or the consummation of the
transactions contemplated hereby or thereby, except for (i) the filing of a Form
D under the Securities Act of 1933, as amended (the "Securities Act"), (ii) such
filings as may be required under applicable state securities laws or the
Xxxx-Xxxxx-Xxxxxx Antitrust Improvements Act of 1976, as
-5-
amended (the "HSR Act"), and (iii) such other consents, authorizations, filings,
approvals and registrations which, if not obtained or made, would not,
individually or in the aggregate, have a Material Adverse Effect on the Company
and would not materially burden or delay the consummation of the transactions
contemplated hereby.
Section 3.5 CAPITALIZATION.
(a) The authorized capital stock of the Company as of the date hereof
consists of (i) 20,000,000 shares of Common Stock, of which 12,163,619 shares
are issued and outstanding, and (ii) 1,000,000 shares of Preferred Stock, $0.01
par value per share, of which 10,000 shares are issued or outstanding.
(b) The authorized capital stock of the Company as of the Second
Closing Date and immediately prior to the Second Closing shall be as set forth
in Section 3.5(a) hereof, subject, however, to (i) an increase in the authorized
number of shares of Common Stock to 30,000,000, which is contemplated to occur
following the Annual Meeting (as defined in Section 5.6 hereof), (ii) the prior
sale and issuance of the Shares to be issued and sold at the First Closing, (ii)
the grant of options to purchase shares of Common Stock under the Company's
employee stock option plans and the exercise of options outstanding as of the
date hereof and (iii) any other issuance of the Company's capital stock, or
securities convertible into such capital stock, as may be approved by the
Purchaser.
(c) Other than (i) as disclosed in the Company Commission Reports (as
defined below) or in documents incorporated by reference therein, (ii) stock
options and employee stock purchases following the date of the most recent
Company Commission Report under the Company's stock option, stock incentive and
stock purchase plans described in the Company Commission Reports and (iii) as
disclosed on Schedule 3.5(c) hereto, there are no outstanding options, warrants
or commitments of any kind to which the Company is a party or by which it is
bound obligating the Company to
-6-
issue, deliver or sell any shares of capital stock of the
Company.
Section 3.6 COMMISSION FILINGS; FINANCIAL
STATEMENTS.
(a) The Company has filed with the Securities and Exchange Commission
(the "Commission") and made available to the Purchaser and its representatives
all forms, reports and documents filed by the Company with the Commission since
December 31, 1998 (collectively, the "Company Commission Reports"). The Company
Commission Reports (i) at the time filed, complied in all material respects with
the applicable requirements of the Securities Act and the Securities Exchange
Act of 1934, as amended (the "Exchange Act"), as applicable, and (ii) did not at
the time they were filed (or if amended or superseded by a filing prior to the
date of this Agreement, then on the date of such amending or superseding filing)
contain any untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not
misleading.
(b) Each of the financial statements (including, in each case, any
related notes) contained in the Company Commission Reports complied as to form
in all material respects with the applicable published rules and regulations of
the Commission with respect thereto, was prepared in accordance with generally
accepted accounting principles applied on a consistent basis throughout the
periods involved (except as may be indicated in the notes to such financial
statements or, in the case of unaudited statements, as permitted by Form 10-Q of
the Commission) and include all adjustments, consisting only of normal
accounting adjustments, that the Company reasonably considers necessary for a
fair presentation of its financial position at the respective dates and the
results of its operations and cash flows for the periods indicated. Except as
disclosed in the Company Commission Reports filed with the Commission prior to
the date hereof, since December 31, 1998, taking into account the cumulative
effect of all
-7-
developments and events since such date, there has not been any development or
event, or series of developments or events, that would reasonably be expected to
have a Material Adverse Effect.
Section 3.7 COMPLIANCE WITH LAWS. Each of the Company and its subsidiaries
has complied with, is not in violation of, and has not received any notices of
violation with respect to, any federal, state or local statute, law or
regulation with respect to the conduct of its business, or the ownership or
operation of its business, including but not limited to statutes, laws or
regulations relating to the protection of the environment or concerning the
handling, storage, disposal or discharge of toxic materials, except for failures
to comply or violations which would not, individually or in the aggregate, have
a Material Adverse Effect on the Company.
Section 3.8 STOCKHOLDERS' CONSENT. No consent or approval of the
stockholders of the Company is required or necessary for the Company to enter
into this Agreement, the Registration Rights Agreement, the Loan Agreement and
the Convertible Subordinated Note or to consummate the First Purchase. Except
for the requirement pursuant to the NASD Rules that the Second Purchase be
approved by the stockholders of the Company prior to the consummation thereof,
and approval of the Charter Amendment (as defined in Section 5.6 hereof), no
approval of the stockholders of the Company is required for the Company to
consummate the Second Purchase.
Section 3.9 LITIGATION. Except as otherwise disclosed as of the date of
this Agreement in the Company Commission Reports, (i) there is no private or
governmental action, suit, proceeding, claim, arbitration or investigation
pending before any agency, court or tribunal, foreign or domestic, or, to the
knowledge of the Company, threatened against the Company or any of its
subsidiaries or properties or any of its officers or directors (in their
capacities as such), which, if determined adversely to the Company, would,
individually or in the aggregate, have a Material Adverse Effect, and (ii) there
is no judgment,
-8-
decree or order against the Company or any of its subsidiaries, or, to the
knowledge of the Company, against any of its respective directors or officers
(in their capacities as such) relating to the business of the Company or any of
its subsidiaries, the existence of which would have a Material Adverse Effect.
Section 3.10 INTELLECTUAL PROPERTY. Except as disclosed in the Company
Commission Reports, each of the Company and its subsidiaries (i) owns or
possesses adequate licenses or other rights to use all patents, trademarks,
service marks, trade names, copyrights, technology, software, know-how and trade
secrets (collectively, "Intellectual Property") necessary to conduct the
business now conducted by the Company and its subsidiaries and (ii) either owns
or possesses, or can acquire on commercially reasonable terms, adequate licenses
or other rights to use all Intellectual Property necessary to conduct the
business proposed to be conducted by the Company and its subsidiaries. Except as
disclosed in the Company Commission Reports, neither the Company nor any of its
subsidiaries has received any notice of infringement of or conflict with (and
knows of no such infringement of or conflict with) asserted rights of others
with respect to any Intellectual Property; and, to the Company's knowledge, the
discoveries, inventions, products, services or processes used in the business of
the Company and its subsidiaries do not infringe or conflict with any right or
patent of any third party, or any discovery, invention, product or process which
is the subject of a patent application filed by any third party.
Section 3.11 CHANGE OF CONTROL BENEFITS. Except as set forth on Schedule
3.11, there exist no provisions contained in any employment or severance
agreement or benefit plan of the Company which provide for the payment, accrual
or acceleration of any benefit to any person as a result of the consummation of
the transactions contemplated hereby.
Section 3.12 FINDER'S FEES. The Company has retained no finder or broker in
connection with the transactions contemplated by this Agreement and hereby
agrees to
-9-
indemnify and to hold the Purchaser harmless from any liability for commission
or compensation in the nature of a finder's fee to any broker or other person or
firm (and the costs and expenses of defending against such liability or asserted
liability) for which the Company, or any of its employees or representatives
acting on behalf of the Company, is or may be responsible as a result of the
transactions contemplated hereby.
ARTICLE IV
REPRESENTATIONS AND WARRANTIES OF THE PURCHASER
The Purchaser hereby represents and warrants to the Company as follows:
Section 4.1 ORGANIZATION. The Purchaser is a corporation duly organized,
validly existing and in good standing under the laws of the State of Delaware.
Section 4.2 AUTHORITY.
(a) The Purchaser has all requisite corporate power and authority to
enter into this Agreement and to consummate the transactions contemplated by
this Agreement. The execution and delivery of this Agreement and the
consummation of the transactions contemplated by this Agreement have been duly
authorized by all necessary corporate action on the part of the Purchaser. This
Agreement has been duly executed and delivered by the Purchaser and constitutes
a valid and legally binding obligation of the Purchaser, enforceable against the
Purchaser in accordance with its terms, subject to bankruptcy, insolvency,
fraudulent transfer, reorganization, moratorium and similar laws of general
applicability relating to or affecting creditors' rights and to general equity
principles.
(b) No consent, approval, order or authorization of, or registration,
declaration or filing with, any Governmental Entity is required by or with
respect to the Purchaser in connection with the execution and delivery of
-10-
this Agreement or the consummation of the transactions contemplated hereby,
except for (i) the filing of a notification and report form under the HSR Act,
compliance with the rules and regulations thereunder and satisfaction of the
applicable waiting period thereunder, (ii) the filing of a Form D under the
Securities Act, (iii) such filings as may be required under applicable state
securities laws and (iv) such other consents, authorizations, filings, approvals
and registrations which, if not obtained or made, would not materially burden or
delay the consummation of the transactions contemplated hereby.
Section 4.3 PURCHASE ENTIRELY FOR OWN ACCOUNT. The Shares will be acquired
solely for investment purposes, for the Purchaser's own account, not as a
nominee or agent, and not with a view to the resale or distribution of any part
thereof; provided, however, that, notwithstanding the foregoing, it is
understood and acknowledged that prior to, on or following the First Closing
Date, (i) the Purchaser may transfer all or a portion of the Shares purchased by
it hereunder to SOFTBANK Capital Partners or (ii) the Purchaser may assign its
rights to purchase any or all of the Shares to be purchased by it hereunder to
SOFTBANK Capital Partners, in which event such Shares will be purchased by
SOFTBANK Capital Partners. The Purchaser has not been formed for the specific
purpose of acquiring the Shares.
Section 4.4 INVESTMENT EXPERIENCE. Purchaser is an "accredited investor" as
defined in Rule 501(a) under the Securities Act. Purchaser has had an
opportunity to ask questions and receive answers regarding the Company's
business affairs and financial condition and believes it has acquired sufficient
information about the Company to reach an informed decision to purchase the
Shares. Purchaser has such business and financial experience as is required to
give it the capacity to protect its own interests in connection with the
purchase of the Shares.
Section 4.5 RESTRICTED SECURITIES. The Purchaser understands that the
Shares are characterized as "restricted securities" under the Securities Act
inasmuch as they are being acquired from the Company in a transaction not
-11-
involving a public offering and that Purchaser must hold the Shares indefinitely
unless the sale thereof is registered under the Securities Act and qualified
under state securities laws, or an exemption from such registration and
qualification requirements is available. The Purchaser further acknowledges that
if an exemption from registration or qualification is available, it may be
conditioned on various requirements including, but not limited to, the time and
manner of sale, the holding period for the Shares, and on requirements relating
to the Company which are outside of the Purchaser's control.
Section 4.6 LEGENDS. The Purchaser understands that the Shares, and any
securities issued in respect thereof or exchange therefor, may bear one or all
of the following legends until such time, if any, as the Shares or such
securities (i) are sold in compliance with Rule 144 under the Securities Act (or
a comparable successor provision) or in a transaction registered under the
Securities Act or (ii) may be resold pursuant to Rule 144(k) under the
Securities Act (or a comparable successor provision):
"THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT
WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH
SALE OR DISTRIBUTION MAY BE EFFECTED EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT RELATED THERETO OR AN APPLICABLE EXEMPTION THEREFROM AND
IN COMPLIANCE WITH THE TERMS OF THE STOCK PURCHASE AGREEMENT, DATED AS OF JUNE
10, 1999, WITH THE COMPANY, A COPY OF WHICH IS AVAILABLE FROM THE COMPANY ON
REQUEST."
Section 4.7 FINDER'S FEES. The Purchaser has not retained any finder or
broker in connection with the transactions contemplated by this Agreement and
hereby agrees to indemnify and to hold the Company harmless from any liability
for any commission or compensation in the nature of a finder's fee to any broker
or other person or firm (and the costs and expenses of defending against such
liability or asserted liability) for which the Purchaser, or any of its
employees or representatives acting on behalf of
-12-
the Purchaser, is or may be responsible as a result of the transactions
contemplated hereby.
ARTICLE V
COVENANTS
Section 5.1 HSR ACT FILINGS.
(a) The Purchaser shall make all filings required under the HSR Act
relating to the transactions contemplated by this Agreement and shall use
commercially reasonably efforts to cause any such required filings to be made
promptly after the date hereof.
(b) The Company shall make all filings required under the HSR Act
relating to the transactions contemplated by this Agreement and shall use
commercially reasonable efforts to cause any such required filings to be made
promptly after the date hereof.
(c) The parties will each use commercially reasonable efforts to
promptly furnish, or, cause to be furnished, any information that may be
required by the Federal Trade Commission (the "FTC") or the Department of
Justice (the "DOJ") under the HSR Act in order for the requisite approvals for
the purchase and sale of the Shares and the consummation of the related
transactions contemplated by this Agreement to be obtained or any applicable
waiting periods to be terminated or expire; provided, however, that in the event
the FTC or the DOJ issues a "second request" in connection with any such filing,
the parties hereto will consult with each other in good faith regarding
appropriate further action, which shall be taken only to the extent agreed upon
by all of the parties.
Section 5.2 TRANSFER RESTRICTIONS.
(a) The Purchaser shall not, directly or indirectly, sell, transfer,
assign, pledge or otherwise dispose of any interest in any of the Shares
acquired
-13-
hereunder for a period of one (1) year following the First Closing Date (the
"Holding Period"); provided, however, that such agreement shall not be deemed to
limit the Purchaser's right to consummate a merger or other corporate
transaction involving a change of control of the Purchaser as a result of which
Shares may be deemed to be transferred by operation of law to a successor in
interest of the Purchaser; provided, further, that, notwithstanding anything in
this Section 5.2(a) to the contrary, but subject to Section 5.2(b), the
Purchaser shall be permitted to sell, transfer, assign or pledge all or any part
of the Shares to any affiliates of Purchaser or SOFTBANK Corp., a Japanese
corporation, including, without limitation, SOFTBANK Capital Partners and any
other partnership or other entity of which any direct or indirect subsidiary of
SOFTBANK Corp. is a general partner or has investment discretion, or any
employees of any of the foregoing (any such person or entity being herein
referred to as a "SOFTBANK Entity"). The Purchaser shall not sell or transfer
the Shares or any interest therein except in compliance with the Securities Act,
applicable state securities laws and this Agreement.
(b) Prior to, and as a condition to, any transfer referred to in the
second proviso to the first sentence of Section 5.2(a), the transferee shall
agree in writing, for the benefit of the Company, to be bound by the transfer
restrictions set forth in this Section 5.2.
Section 5.3 BOARD OF DIRECTORS. On and after the First Closing Date, the
Purchaser shall have the right to designate (i) a number of members of the
Company's Board of Directors equal to the product of (A) the total number of
authorized directors and (B) the aggregate Proportionate Share (as defined
below) of the Purchaser and the SOFTBANK Entities on the Company's Board of
Directors, rounded up to the nearest whole number, but not to exceed two
directors (the "Board Composition Requirement"), and (ii) so long as the
Purchaser and the SOFTBANK Entities collectively own 50% or more of the Shares
theretofore purchased hereunder, the Purchaser shall have the right to designate
one director to be a member of each committee of the Company's Board of
Directors.
-14-
Section 5.4 PREEMPTIVE RIGHTS.
(a) If the Company proposes to issue, grant or sell Common Stock or
Rights, the Company shall first give to the Purchaser (so long as the Purchaser
owns at least 500,000 Shares) and any transferee of Shares from the Purchaser
then owning at least 500,000 Shares (appropriately adjusted for any stock split,
reverse stock split or stock dividend), except for any transferee that acquires
such Shares in a public offering registered under the Securities Act or in a
transaction on the open market effected pursuant to Rule 144 under the
Securities Act, (each a "Securityholder") written notice setting forth in
reasonable detail the price and other terms on which such shares of Common Stock
or Rights are proposed to be issued or sold, the terms of any such Rights and
the amount thereof proposed to be issued, granted or sold. Each Securityholder
shall thereafter have the preemptive right, exercisable by written notice to the
Company no later than twenty (20) days after the Company's notice is given, to
purchase the number of such shares of Common Stock or Rights set forth in the
Securityholder's notice (but in no event more than the Securityholder's
Proportionate Share (as defined below) thereof, as of the date of the Company's
notice), at the price and on the other terms set forth in the Company's notice.
Any notice by a Securityholder exercising the right to purchase shares of Common
Stock or Rights pursuant to this Section 5.4 shall constitute an irrevocable
commitment to purchase from the Company the shares of Common Stock or Rights
specified in such notice, subject to the maximum set forth in the preceding
sentence. If all the Securityholders exercise their preemptive rights set forth
in this Section 5.4(a) to the full extent of their Proportionate Share or if for
any other reason the Company shall not issue, grant or sell shares of Common
Stock or Rights to persons other than Securityholders, then the closing of the
purchase of shares of Common Stock or Rights by Securityholders shall take place
on such date, no less than ten (10) and no more than thirty (30) days after the
expiration of the 20-day period referred to above, as the Company may select,
and the Company shall notify the Securityholders of such closing at least seven
(7) days prior thereto. If all persons entitled
-15-
thereto do not exercise their preemptive rights to the full extent of their
Proportionate Share and, as contemplated by Section 5.4(b), the Company shall
issue, grant or sell shares of Common Stock or Rights to persons other than
Securityholders, then the closing of the purchase of shares of Common Stock or
Rights shall take place at the same time as the closing of such issuance, grant
or sale.
(b) If all persons entitled thereto do not exercise their preemptive
rights to the full extent of their Proportionate Share, the Company shall use
its good faith and commercially reasonable efforts to issue, grant or sell the
remaining subject shares of Common Stock or Rights on the terms set forth in its
notice to Securityholders, unless the Company is advised by its financial
advisors that the remaining number or amount is too small to be reasonably sold.
From the expiration of the 20-day period first referred to in Section 5.4(a) and
for a period of 90 days thereafter, the Company may offer, issue, grant and sell
to any person or entity shares of Common Stock or Rights having the terms set
forth in the Company's notice relating to such shares of Common Stock or Rights
at a price and on other terms no less favorable to the Company, and including no
less cash, than those set forth in such notice (without deduction for reasonable
underwriting, sales agency and similar fees payable in connection therewith);
provided, however, that the Company may not issue, grant or sell shares of
Common Stock or Rights in an amount greater than the amount set forth in such
notice minus the amount purchased or committed to be purchased by
Securityholders rights.
(c) The provisions of this Section 5.4 shall not apply to the
following issuances of securities: (i) pursuant to an approved stock option
plan, stock purchase plan, or similar benefit program or agreement for the
benefit of employees of, or consultants to, the Company, where the primary
purpose is not to raise additional equity capital for the Company, (ii) the
issuance of Rights, or Common Stock issuable upon exercise of Rights, granted to
retailers or lessors engaged in bona fide business transactions with the
Company, where the primary purpose is not to raise
-16-
additional equity capital for the Company, (iii) as direct consideration for the
acquisition by the Company of another business entity or the merger of any
business entity with or into the Company, (iv) in connection with a stock
dividend, (v) upon the exercise of warrants or options, or upon the conversion
of convertible securities, outstanding on the date hereof or as to which
Securityholders have been previously offered the right to participate as
contemplated hereby or (vi) in an underwritten public offering registered under
the Securities Act if the managing underwriters advise the Securityholders in
writing that the purchase of shares of Common Stock pursuant to the preemptive
rights afforded by this Section 5.4 would materially and adversely affect the
marketing of the offering.
(d) For purposes of this Section 5.4, the following terms shall have
the corresponding meanings set forth herein:
"Proportionate Share" means, with respect to each Securityholder, a
fraction the numerator of which is the total number of shares of Common Stock
owned and the number of shares of Common Stock issuable upon exercise of Rights
owned by such Securityholder, and the denominator of which is the total number
of shares of Common Stock outstanding plus the number of shares of Common Stock
issuable upon exercise of all Rights outstanding.
"Right" means any option, warrant, security, right or other instrument
convertible into or exchangeable or exercisable for, or otherwise giving the
holder thereof the right to acquire, directly or indirectly, from the Company
any Common Stock or any other such option, warrant, security, right or
instrument, including any instrument issued by the Company or any subsidiary
thereof the value of which is measured by reference to the value of the Common
Stock.
Section 5.5 ALTERNATIVE TRANSACTIONS. The Company covenants that prior to
the earlier of (i) the Second Closing Date and (ii) the date 90 days after the
date hereof, (A) neither the Company nor any of its officers,
-17-
directors, advisors, agents or any other person or entity acting on behalf of
any or all of them (collectively, "Representatives") shall, directly or
indirectly, initiate, solicit, induce, support, encourage (including, without
limitation by providing non-public information), agree to, or enter into any
alternative proposal, negotiation or transaction for an investment in or sale of
newly-issued equity interests in or voting securities of the Company (an
"Alternative Transaction") and (B) in the event the Company receives any
proposal for an Alternative Transaction, the Company shall promptly notify the
Purchaser of the receipt of such proposal; provided, however, that this Section
5.5 shall not restrict the Company's ability to incur bona fide indebtedness
that is not convertible into or exchangeable for any equity security of the
Company; provided, further, that, notwithstanding this Section 5.5, the Company
may issue or sell in a transaction pursuant to a bona fide offer from a third
party (x) its Common Stock at a price per share of not less than $13.00 (the
"Minimum Price") and (y) convertible debt securities or convertible preferred
securities at a conversion price per share not less than the Minimum Price, in
each case (x) and (y) provided that the Purchaser is previously offered in
writing the opportunity to purchase such securities on the same terms as, or on
terms more favorable to the Purchaser than, those offered by such third party
(it being understood that (i) such written offer to the Purchaser shall identify
the third party offeror and describe with specificity the terms of the
transaction proposed to be consummated with such third party and (ii) the
Purchaser shall exercise such right of first refusal within 2 business days
after receipt of such notice). In the event of a stock split, reverse stock
split or stock dividend involving the Company, the Minimum Price shall be
appropriately adjusted.
Section 5.6 MEETING OF THE COMPANY STOCKHOLDERS. The Company shall take all
customary actions in accordance with applicable law and its Certificate of
Incorporation and By-Laws to seek stockholder approval by the holders of a
majority of the outstanding shares of Common Stock at the annual meeting of
stockholders to be held on or before July 13, 1999 (the "Annual Meeting") (i) of
the Second
-18-
Purchase as contemplated hereby, (ii) of an amendment to the Company's
certificate of incorporation increasing the authorized number of shares of
Common Stock to 30,000,000 (the "Charter Amendment") and (iii) of election of a
Board of Directors meeting the Board Composition Requirements (calculated in a
manner that gives effect to the purchase of the Shares to be purchased at the
Second Closing). The Board of Directors of the Company shall recommend such
approval, and the Company shall solicit such approval in accordance with its
customary practices. No amendment or supplement to the proxy statement
soliciting proxies in connection with such Annual Meeting shall be filed or made
by the Company without prior consultation with the Purchaser and its counsel.
Section 5.7 PUBLICITY. The Company and the Purchaser shall consult with
each other prior to issuing any press releases or otherwise making public
statements with respect to the transactions contemplated hereby and prior to
making any filings with any federal or state governmental or regulatory agency
or any self-regulatory organization with respect thereto.
Section 5.8 LIMITATION ON OWNERSHIP OF COMMON STOCK. Commencing on the
First Closing Date and prior to the fifth anniversary thereof, the Purchaser
shall not acquire beneficial ownership of any Common Stock or any Rights
(except, in any case, by way of stock dividends, stock splits or other
distributions or offerings made available to holders of Common Stock generally)
without the written consent of the Company, if the effect of such acquisition
would be to increase the Purchaser's Proportionate Share to greater than 35%;
provided, however, that:
(i) Nothing herein shall prevent the Purchaser from acquiring Common
Stock or Rights if it is publicly disclosed or the Purchaser otherwise learns
that any person or persons acting together that would constitute a "group" for
purposes of Section 13(d) of the Exchange Act (a "Group") has acquired or
proposes to acquire, immediately or at some later date, beneficial ownership
(within the meaning of Rule 13(d)-3 under the Exchange Act) of Common Stock
-19-
which results or would result in such person or Group (other than Xxxxxxx X.
Xxxxx, any member of Xx. Xxxxx'x immediate family or any trust of which the
beneficiaries are Xx. Xxxxx and/or members of his immediate family) benefi-
cially owning Common Stock in excess of the maximum number of shares of Common
Stock the Purchaser is then permitted to acquire hereunder; provided that the
number of additional shares of Common Stock acquired by the Purchaser pursuant
to this paragraph (i) when added to the Common Stock then beneficially owned by
the Purchaser shall not exceed the number of shares of Common Stock beneficially
owned or proposed to be beneficially owned by such other person or Group;
(ii) Nothing herein shall prevent the Purchaser from acquiring Common
Stock or Rights, without regard to the limitations of this Section, if a tender
or exchange offer is made as evidenced by the filing with the Securities and
Exchange Commission of a Statement on Schedule 14D-1 (or any successor schedule
or form promulgated or adopted for such purpose) and the actual dissemination of
tender offer materials to securityholders by any person or Group (not including
the Company or the Purchaser) which offers to purchase or exchange for cash or
other consideration Common Stock which, if added to the Common Stock (if any)
already owned by such person or Group would result in such person or Group
beneficially owning Common Stock representing more than 30% of the then
outstanding Common Stock; and
(iii) The Purchaser shall not be obligated to dispose of any Common
Stock if the Purchaser's Proportionate Share is increased as a result of (a) any
actions taken by the Purchaser which are permitted under paragraph (i) or (ii)
of this Section 5.8, (b) a recapitalization of the Company or (c) a repurchase
of any shares of Common Stock by the Company or any other action taken by the
Company or its affiliates or associates.
Section 5.9 FULFILLMENT OF CONDITIONS. Each of the Company and the
Purchaser shall use reasonable efforts to perform, comply with and fulfill all
obligations, covenants and conditions required by this Agreement to be
performed,
-20-
complied with or fulfilled on its part prior to or at the Closing Dates.
Section 5.10 FURTHER ASSURANCES. The Company shall use its reasonable
efforts at any time and from time to time prior to, at and after the Closings to
execute and deliver to the Purchaser such further documents and instruments and
to take all such further actions as the Purchaser reasonably may request in
order to convey and transfer the Shares to the Purchaser and to consummate the
transactions contemplated by this Agreement and the Registration Rights
Agreement.
ARTICLE VI
CONDITIONS TO CLOSING
Section 6.1 CONDITIONS TO THE PURCHASER'S OBLIGATIONS. The obligation of
the Purchaser to purchase the Shares at each Closing is subject to the
fulfillment on or prior to the relevant Closing Date of the following
conditions:
(a) REPRESENTATIONS AND WARRANTIES CORRECT; PERFORMANCE OF
OBLIGATIONS. The representations and warranties made by the Company in Article
III hereof shall be true and correct in all material respects as of the date of
this Agreement and as of such Closing Date (except with respect to
representations and warranties made as of a specific time, which shall be true
in all material respects as of such time, and except for representations and
warranties containing a materiality qualification, which must be true in all
respects) with the same effect as though such representations and warranties had
been made at and as of such Closing Date, provided, however, that the
representation set forth in Section 3.5(c) shall be deemed true in all material
respects as of such Closing Date so long as the Company updates Schedule 3.5(c)
as of such Closing Date; and the Company shall have performed all obligations
herein required to be performed by it on or prior to such Closing Date in all
material respects (except with respect to obligations containing a materiality
qualification, which must be performed in all respects).
-21-
(b) REGISTRATION RIGHTS AGREEMENT. The Company shall have duly
executed and delivered the Registration Rights Agreement.
(c) VOTING AGREEMENT. Xxxxxxx X. Xxxxx shall have duly executed and
delivered the Voting Agreement in the form attached hereto as Exhibit C.
(d) BOARD COMPOSITION. A Board of Directors meeting the Board
Composition Requirement applicable after giving effect to the purchase of the
Shares to be purchased at such Closing shall have been duly established and in
place.
(e) STOCKHOLDER APPROVAL. With respect to the Second Closing,
stockholders of the Company holding a majority of the outstanding shares of
Common Stock shall have approved the Second Purchase and the Charter Amendment
as provided herein.
(f) COMPLIANCE CERTIFICATE. The President of the Company shall deliver
to the Purchaser at such Closing a certificate certifying that the conditions
specified in Section 6.1(a) have been fulfilled.
(g) OPINION OF COMPANY'S COUNSEL. The Purchaser shall have received
from Blank, Rome, Xxxxxxx & XxXxxxxx LLP, counsel to the Company, an opinion
addressed to the Purchaser, dated such Closing Date, reasonably satisfactory in
form and substance to Xxxxxxxx & Xxxxxxxx, counsel to the Purchaser.
(h) NO INJUNCTION, ORDER, ETC. There shall be no injunction, order or
decree of any nature of any court or government authority of competent
jurisdiction that is in effect that restrains or prohibits the consummation of
the transactions contemplated hereby.
(i) WAITING PERIOD. Any waiting period applicable to the sale of the
Shares under the HSR Act shall have expired or been terminated.
-22-
Section 6.2 CONDITIONS TO OBLIGATIONS OF THE COMPANY. The Company's
obligation to issue and sell the Shares at each Closing is subject to the
fulfillment on or prior to the relevant Closing Date of the following
conditions:
(a) REPRESENTATIONS AND WARRANTIES CORRECT; PERFORMANCE OF
OBLIGATIONS. The representations and warranties of the Purchaser in Article IV
hereof shall be true and correct in all material respects as of the date of this
Agreement and as of such Closing Date (except with respect to representations
and warranties made as of a specific time, which shall be true in all material
respects as of such time, and except for representations and warranties
containing a materiality qualification, which must be true in all respects) with
the same effect as though such representations and warranties had been made at
and as of such Closing Date; and the Purchaser shall have performed all
obligations herein required to be performed by it on or prior to such Closing
Date in all material respects (except with respect to covenants containing a
materiality qualification, which must be performed in all respects).
(b) REGISTRATION RIGHTS AGREEMENT. The Purchaser shall have duly
executed and delivered the Registration Rights Agreement.
(c) VOTING AGREEMENT. The Purchaser shall have duly executed and
delivered the Voting Agreement in the form attached hereto as Exhibit D.
(d) STOCKHOLDER APPROVAL. With respect to the Second Closing,
stockholders of the Company holding a majority of the outstanding shares of
Common Stock shall have approved the Second Purchase and the Charter Amendment
as provided herein.
(e) NO INJUNCTION, ORDER, ETC. There shall be no injunction, order or
decree of any nature of any court or government authority of competent
jurisdiction that is in effect that restrains or prohibits the consummation of
the transactions contemplated hereby.
-23-
(f) WAITING PERIOD. Any waiting period applicable to the sale of the
Shares under the HSR Act shall have expired or been terminated.
ARTICLE VII
INDEMNIFICATION
Section 7.1 INDEMNIFICATION. Each of the Company and the Purchaser (an
"Indemnifying Party") covenants and agrees to indemnify and hold the other (the
"Indemnified Party") harmless from and against, and to reimburse the Indemnified
Party for, any claim for any losses, damages, liabilities or expenses, including
reasonable counsel fees (collectively "Damages") incurred by such Indemnified
Party by reason of or arising from (i) any misrepresentation or breach of any
representation or warranty of such Indemnifying Party contained in this
Agreement or in any instrument delivered hereunder or (ii) any failure by such
Indemnifying Party to perform any obligation or covenant required to be
performed by it under any provision of this Agreement.
ARTICLE VIII
MISCELLANEOUS
Section 8.1 GOVERNING LAW. This Agreement shall be governed by, and
construed in accordance with, the laws of the State of Delaware.
Section 8.2 SURVIVAL. The representations, warranties, covenants and
agreements made herein shall survive the closing of the transactions
contemplated hereby.
Section 8.3 SUCCESSORS AND ASSIGNS. Except as expressly provided herein,
the rights and obligations hereunder may not be assigned or delegated by the
Purchaser or the Company without the prior written consent of the other;
provided, however, that Purchaser may assign, in whole or in part, its rights
and delegate its obligation, hereunder (including, without limitation, the right
to purchase any or all of the Shares and the obligation to pay
-24-
all or any portion of the Purchase Price for the Shares) to any SOFTBANK Entity;
provided, further, that any such delegation by the Purchaser of its obligations
shall not relieve Purchaser of liability to the Company that it would otherwise
have in the event such obligations are not performed. The provisions hereof
shall inure to the benefit of, and be binding upon, the successors and permitted
assigns of the parties hereto.
Section 8.4 ENTIRE AGREEMENT; AMENDMENT. This Agreement constitutes the
full and entire understanding and agreement among the parties with regard to the
subject matter hereof. Any term of this Agreement may be amended and the
observance of any term of this Agreement may be waived (either generally or in a
particular instance and either retroactively or prospectively), only with the
written consent of the Company and the Purchaser.
Section 8.5 NOTICES AND OTHER COMMUNICATIONS. Every notice or other
communication required or contemplated by this Agreement by either party shall
be delivered either by (i) personal delivery, (ii) postage prepaid return
receipt requested by registered or certified mail, (iii) overnight courier, such
as Federal Express or UPS, or (iv) facsimile with a confirmation copy sent
simultaneously by postage prepaid, return receipt requested, registered or
certified mail, in each case addressed to the Company or the Purchaser as the
case may be at the following address:
To the Company: Global Sports, Inc.
000 Xxxxx Xxxxxxxxx Xxxx
Xxxx xx Xxxxxxx, Xxxxxxxxxxxx 00000
Telephone: (000) 000-0000
Facsimile: (000) 000-0000
Attn: Xxxxxxx X. Xxxxx
-25-
With a copy to:
Blank Rome Xxxxxxx & XxXxxxxx LLP
Xxx Xxxxx Xxxxxx
Xxxxxxxxxxxx, Xxxxxxxxxxxx 00000
Attn: Xxxxxx Xxxxxx, Esq.
Telephone: (000) 000-0000
Facsimile: (000) 000-0000
To the Purchaser: SOFTBANK Holdings Inc.
00 Xxxxxxx Xxxx, Xxxxx 000
Xxxxxx Xxxxxx, XX 00000
Attn: Xxxxxx X. Xxxxxx
Facsimile: (000) 000-0000
SOFTBANK America Inc.
000 Xxxxxxxx Xxxxxx, Xxxxx 000
Xxxxxxxxxx, Xxxxxxxx 00000
Attn: Xxxxxxx Xxxxxx
Facsimile: (000) 000-0000
With a copy to: Xxxxxxxx & Xxxxxxxx
0000 Xxxxxxx Xxxx Xxxx
Xxxxx 0000
Xxx Xxxxxxx, XX 00000
Attn: Xxxx X. Xxxxx, Esq.
Facsimile: (000) 000-0000
or at such other address as the intended recipient previously shall have
designated by written notice given in like manner to the other party. Notice by
registered or certified mail shall be effective on the date it is officially
recorded as delivered to the intended recipient by return receipt or equivalent,
and in the absence of such record of delivery, the effective date shall be
presumed to have been the fifth (5th) business day after it was deposited in the
mail. All notices delivered in person or sent by courier shall be deemed to have
been delivered to and received by the addressee and shall be effective on the
date of personal delivery; notices delivered by facsimile with simultaneous
confirmation copy by registered or
-26-
certified mail shall be deemed delivered to and received by the addressee and
effective on the date sent. Notice not given in writing shall be effective only
if acknowledged in writing by a duly authorized representative of the party to
whom it was given.
Section 8.6 DELAYS OR OMISSIONS. No delay or omission to exercise any
right, power or remedy accruing to any person or entity hereunder shall impair
any such right, power or remedy nor shall it be construed to be a waiver of any
such breach or default, or an acquiescence therein, or of or in any similar
breach or default thereafter occurring; nor shall any waiver of any single
breach or default be deemed a waiver of any other breach or default theretofore
or thereafter occurring. Any waiver, permit, consent or approval of any kind or
character on the part of any person or entity hereunder of any breach or default
under this Agreement, or any waiver on the part of any such person or entity of
any provisions or conditions of this Agreement, must be in writing and shall be
effective only to the extent specifically set forth in such writing. All
remedies either under this Agreement, or by law or otherwise shall be cumulative
and not alternative.
Section 8.7 SEVERABILITY. In case any provision of this Agreement shall be
invalid, illegal or unenforceable, the validity, legality and enforceability of
the remaining provisions shall not in any way be affected or impaired thereby.
Section 8.8 COUNTERPARTS. This Agreement may be executed in any number of
counterparts, each of which shall be an original, but all of which together
shall constitute one instrument. Execution and delivery of this Agreement by
exchange of facsimile copies bearing the facsimile signature of a party hereto
shall constitute a valid and binding execution and delivery of this Agreement by
such party.
Section 8.9 ATTORNEYS' FEES. If any action or proceeding shall be commenced
to enforce this Agreement or any right arising in connection with this
Agreement, the prevailing party in such action or proceeding shall be
-27-
entitled to recover from the other party the reasonable attorneys' fees, costs
and expenses incurred by such prevailing party in connection with such action or
proceeding.
-28-
IN WITNESS WHEREOF, the parties have executed this Agreement as of the date
and year first above written.
GLOBAL SPORTS, INC.
By:____________________________
Name:
Title:
SOFTBANK AMERICA INC.
By:____________________________
Name:
Title:
-29-
EXHIBIT A
SCHEDULE OF PURCHASES BY PURCHASER
FIRST CLOSING
SHARES PURCHASED 2,432,692
PURCHASE PRICE $31,624,996
SECOND CLOSING
SHARES PURCHASED 3,721,158
PURCHASE PRICE $48,375,054
TOTAL SHARES PURCHASED 6,153,850
TOTAL PURCHASE PRICE $80,000,050
-30-
EXHIBIT B
REGISTRATION RIGHTS
AGREEMENT
-31-
EXHIBIT C
VOTING AGREEMENT
-32-
